←
St. Jude Research10,190 posts
St. Jude Research avatar✓

St. Jude Research ✓

@StJudeResearch

Driving discoveries and innovative treatments for childhood cancer and other diseases. Ranked #3 by USNWR. #StJude #StJudeResearch

◷ Joined November 2011▧ 6,054 Photos and videos
St. Jude Research avatar
St. Jude Research@StJudeResearch·19h

Scientists developed a cell type-specific protein atlas of Alzheimer’s disease models, identifying more than 3,000 altered proteins. Of these changes, 78% had not been captured previously. Findings reveal a potential communication network in which proteins produced by one brain cell type are secreted and function in another. The first cell-type-resolved proteomic analysis provides new insight into Alzheimer’s disease biology and potential targets for therapeutic studies.​ bit.ly/4zpFEDW

St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 16

The 13th season of The Science of Childhood Cancer virtual lecture series concludes Thursday with Marcin Wlodarski, MD, PhD, St. Jude Bone Marrow Failure Program director. His talk will discuss how adaptive clonal hematopoiesis can protect against leukemia development and reshape our understanding of bone marrow failure.​ Attend the final lecture: bit.ly/4hkFOHz

Post attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 14

St. Jude is expanding neuroscience research across developmental neurobiology, genomic medicine, neural circuitry and neurological disease. At #SfN26, visit St. Jude at booth 2819 and explore our research and poster presentations. bit.ly/4AoAF7A

0:27
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 13

St. Jude hosted researchers, clinicians, policymakers and advocates for the @NatureConf, “Accelerating Pediatric Cancer Innovation: From Research to Real-World Impact.” The conference explored advances in pediatric cancer research and care alongside strategies to address disparities and strengthen health systems. “Our shared ambition is a future in which every child can benefit from progress, wherever they live,” said Carlos Rodriguez-Galindo, MD.

Post attachmentPost attachmentPost attachmentPost attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 13

Researchers at St. Jude and @Columbia used high-speed, wide-field optical mapping to uncover a previously hidden map in the brain that helps organize movement across different parts of the body. The findings offer a new way to study how movement signals are coordinated across the brain and what happens when those signals are disrupted by neurological disease or brain injury. bit.ly/4k98zIB

St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 12

Christopher Vakoc, MD, PhD, has built his career studying how disrupted gene regulation drives cancer and identifying new ways to target those changes. At St. Jude, he plans to expand his research in acute myeloid leukemia and pediatric sarcoma. Learn more about Vakoc’s experience, passion for training the next generation of scientists and the goals shaping his future research: bit.ly/4C0aMfT

Post attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 11

St. Jude researchers found that the Sonic Hedgehog (SHH) protein directs construction of its own long-range signaling routes by recruiting proteins that drive cytoneme growth. The findings help explain how disruptions in SHH signaling during or after development may contribute to developmental disorders, fibrosis and cancer. bit.ly/4iJZGmf

St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 11

This Veterans Day, St. Jude recognizes military veterans across the institution, including retired U.S. Navy veteran Lyndon Thomas. The Memphis native continues his commitment to protecting others by helping to provide a safe, welcoming environment for St. Jude patients and families.

Post attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 9

This Thursday, Andrew Lo, PhD, @MITSloan, will explore how innovative financing models could help advance biomedical research and therapeutic development during The Science of Childhood Cancer virtual lecture series.​ Tune in: bit.ly/4hkFOHz

Post attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 4

More than 350 disease-causing variants in HBB have been linked to β-thalassemia, but advances in hemoglobin research are opening new paths for treatment. St. Jude scientists are studying complementary strategies to reduce toxic α-globin buildup and restore functional hemoglobin. Their work spans ULK1-regulated cellular recycling, BCL11A, fetal hemoglobin reactivation, CRISPR-Cas9 gene editing, base editing and antisense oligonucleotides. Researchers are continuing to pursue approaches that could make treatment more precise, accessible and scalable. Learn more: bit.ly/4ezpJM3

Post attachmentPost attachmentPost attachmentPost attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 2

The Science of Childhood Cancer virtual lecture series welcomes Ravi Majeti, MD, PhD, @StanfordMed. Hear how new tools are advancing the study of pre-leukemic and leukemia stem cells and informing translational research in AML.​ Join the conversation: bit.ly/4hkFOHz

Post attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Nov 2

St. Jude researchers and their collaborators found that mutations present in B-cell acute lymphoblastic leukemia at diagnosis can predict relapse risk, with their significance varying by leukemia subtype. The findings provide a framework to better identify patients at higher risk of relapse and could eventually help clinicians tailor treatment intensity at diagnosis to prevent recurrence while avoiding unnecessary treatment. bit.ly/4sFk50H

St. Jude Research avatar
St. Jude Research@StJudeResearch·Oct 29

Researchers identified how the methyltransferase METTL13 alters the translation factor eEF1A, revealing mechanisms that help drive cancer development and treatment resistance. The findings highlight a potential therapeutic strategy to inhibit KRAS production in tumors. bit.ly/3Wd2KQu

St. Jude Research avatar
St. Jude Research@StJudeResearch·Oct 29

Anjana Nityanandam, PhD, came to St. Jude in 2016 to build the Human Neural Organoid Laboratory. Today, the lab develops human brain organoids that help researchers study development, disease and potential approaches to treatment. Learn more: bit.ly/4zZswGw

Post attachmentPost attachment
St. Jude Research avatar
St. Jude Research@StJudeResearch·Oct 28

These efforts are helping children receive quality-assured medicines and continue treatment in Mongolia while strengthening the systems needed to sustain childhood cancer care. Read how the Global Platform is bringing greater stability to children, families and health care teams in Mongolia: bit.ly/4jJQzV8